A compelling shift toward tissue-centric immunity: lymphoid niches don’t just initiate responses—they time and constrain them. Brilliant now work from Lukas Altenberger shows that timing of initiating and terminating immune response are equally important.
www.science.org/doi/10.1126/...
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges: @cellpress.bsky.social #ADCs #NSCLC
👏Louise Conilh∙ Virginia Metrangolo ∙ Silvia Crescioli ∙ Janice M. Reichert ∙ Charles Dumontet
share.google/RQjHgbNhRkFP...
Brilliantly synthesized.
Always an absolute treat to listen to Prof. Bruno Silva-Santos. I hope everyone is tuned in and listening to this talk!
👇
Happy #DayofImmunology
The generation of effector CD8+ T cells (TEFF) requires activation of naïve CCR7+ T cells (TN) by dendritic cells (DCs) in lymphoid tissue. How TN-DC interaction duration and signal integration are co...
Come be a part of the #DayofImmunology celebrations by listening to @bsilvasantos.bsky.social talk #nowplaying on Teams! You're in for a treat! #GDTcells #precisionmedicine #ImmunoOnc
teams.microsoft.com/meet/3180038...
Meeting ID: 318 003 815 005 374
Access code: LD39ok9r
Save the date: Upcoming 12th International #GdTcellconf in Wrocław, Poland - May 18-21/2027.
So there is a venue and a date confirmed for next year's conference. Stay tuned for the official announcement.
#gd2027
One less thing to apply for, I guess
commonfund.nih.gov/earlyindepen...
Excited to have @kgandersen.bsky.social at @nyulangone.bsky.social for a departmental seminar talking all things viral #emergence #evolution #transmission
Indian mango season is upon us and it brings me so much joy! #Kesar 🥭
A 14-marker blood test predicting lung cancer years before diagnosis may also identify who could benefit from anti-inflammatory prevention therapy potentially transforming how we approach lung cancer prevention. Congrats to this team!
@charlesswanton.bsky.social
www.cell.com/cell/fulltex...
γδ T cell Forum
ALT: Funny Spock: Wouldn't You Like To Know?
static.klipy.com
Funding OpportunityCurrent Funding OpportunityAnnouncementTitleStatusApplication Due DateContactRFA-RM-26-004NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional)Forecasted. Not solic...
A 14-protein plasma signature identifies individuals benefiting from anti-IL-1β-based
lung cancer risk reduction and demonstrates how diverse tumor-promoting factors converge
on the induction of an al...
